Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06782295 · ClinicalTrials.gov registry record · Phase 4
The Use of CCK vs PS in Revision TKAs
A Phase 4 study of Aseptic Loosening of Prosthetic Joint and Instability of Prosthetic Joint, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT06782295: Recruiting Phase 4 study of Aseptic Loosening of Prosthetic Joint and Instability of Prosthetic Joint, sponsored by Rush University Medical Center.
NCT06782295 is a Phase 4 study of Aseptic Loosening of Prosthetic Joint and Instability of Prosthetic Joint that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 170 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06782295, a Phase 4 study of Aseptic Loosening of Prosthetic Joint and Instability of Prosthetic Joint, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to compare the clinical impact of Constrained Condylar versus Posterior Stabilized Knee (PS) bearings on patient satisfaction and surgical outcomes including mid-term survivorship among patients undergoing revision total knee arthroplasty.
Primary Outcome
patients will be asked pre and post operatively to completed standard of care patient reported outcomes to compare over time. The clinical patient reported outcomes of a revision total knee replacement to detect a 6-point difference in knee society score (KSS)
Conditions Studied
Interventions
- DEVICE Constrained Condylar bearing
- DEVICE posterior stabilized bearing
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2038-07-01 |
| Phase | Phase 4 |
What NCT06782295 shows while recruiting
NCT06782295 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (67% lower).
The record links to 5 conditions, with Aseptic Loosening of Prosthetic Joint appearing as the primary indexed condition, and to 2 interventions - of which Constrained Condylar bearing is the first listed.
NCT06782295 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06782295 about?
NCT06782295 is a clinical study titled "The Use of CCK vs PS in Revision TKAs". This study aims to compare the clinical impact of Constrained Condylar versus Posterior Stabilized Knee (PS) bearings on patient satisfaction and surgical outcomes including mid-term survivorship among patients undergoing revision total knee arthroplasty.
What is the current status of trial NCT06782295?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 170 participants. The study started on 2025-07-01. Estimated completion is 2038-07-01.
What conditions does trial NCT06782295 study?
This clinical trial studies the following conditions: Aseptic Loosening of Prosthetic Joint, Instability of Prosthetic Joint, Reimplantation for Periprosthetic Joint Infection, Femoral Revision Indicated, Tibial Component Revision.
What interventions are being tested in trial NCT06782295?
The interventions under investigation include: Constrained Condylar bearing (DEVICE), posterior stabilized bearing (DEVICE).
Who is sponsoring clinical trial NCT06782295?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06782295 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06782295's enrollment target sits among peer trials
170 484th of 2000 higher than 1,515 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI